Kua Liu
State Key Laboratory Of Pharmaceutical Biotechnology
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8+ T cells.
Journal: Communications medicine
Published: February 27, 2025
Correction: SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy.
Journal: Cell death and differentiation
Published: February 06, 2025
EGFR bypass activation mediates acquired resistance to regorafenib in hepatocellular carcinoma.
Journal: Frontiers in medicine
Published: July 14, 2024
SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy.
Journal: Cell death and differentiation
Published: June 28, 2024
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway.
Journal: Cancer biology & therapy
Published: February 20, 2024
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.
Journal: Cell reports. Medicine
Published: October 20, 2023
Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway.
Journal: Heliyon
Published: August 25, 2023
CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma.
Journal: Translational oncology
Published: August 15, 2023
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies.
Journal: Cell & bioscience
Published: February 09, 2023
A novel approach for the analysis of single-cell RNA sequencing identifies TMEM14B as a novel poor prognostic marker in hepatocellular carcinoma.
Journal: Scientific reports
Published: January 05, 2023
Hypoxia signaling in cancer: Implications for therapeutic interventions.
Journal: MedComm
Published: August 03, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026